<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Freiburg_Labjournals_irif_July skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Freiburg/Labjournals/irif/July</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>&quot;&quot;</TITLE></P><DIV id="header"><DIV id="naviconwrapper"><DIV id="naviconbar"><DIV id="navicons"><UL><LI id="home"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="team"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="results"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="policy" style="font-size:11px"><A href="https://2015.igem.org/Team:Freiburg/Practices">Human Practice</A></LI><LI id="notebook"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL></DIV></DIV></DIV><DIV id="navtextwrapper"><DIV id="navtext"><UL id="project-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Overview">Introduction</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/System">Overview</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Design">Diagnostics today</A></LI><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/DNA_Engineering">DNA Engineering</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Cellfree_Expression">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Protein_Purification">Protein Purification</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Surface_Chemistry">Surface Chemistry</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/iRIf">Optical Detection</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Future_Directions">Outlook</A></LI><UL id="team-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Team">Members</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Attributions">Acknowledgements</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Partners">Partners</A></LI></UL><UL id="results-sub"><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results">Main Results</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Diagnostics">Diagnostics</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Own_Device">Our Device</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Immobilization">DNA Array</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Cellfree">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Surface">Binding on Surface</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Modeling">Modeling</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Parts">BioBricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Collaborations">Collaborations</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/InterLab_Study">Interlab Study</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Achievements">Achievements</A></LI><UL id="policy-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Science_Fair">Science Fair</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Theater_Project">Theater Project</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Public_Opinion">Public Opinion</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/College">College Talk</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Ethics">Ethics</A></LI></UL><UL id="notebook-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Labjournals">Labjournals</A></LI><LI><A class="navsub1 subsubmenu" href="#">Techniques</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Classic_vs_Gibson">Gibson</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Coli_Strains">E.coli Strains</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Protocols">Protocols</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Materials">Materials</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Safety">Safety</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Wikimigration">Wiki-Tricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Glossary">Glossary</A></LI></DIV></DIV></DIV><DIV class="clearfix" id="smallnav"><UL class="clearfix"><LI id="home_small"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project_small"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="results_small"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="team_small"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="policy_small"><A href="https://2015.igem.org/Team:Freiburg/Practices">Practice</A></LI><LI id="notebook_small"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL><A href="#" id="pull">Menu</A></DIV><DIV class="content_background_wrapper"><DIV class="central_position_wrap"><DIV class="page_content"><DIV class="button_back"><A style="color:#FFF" href="https://2015.igem.org/Team:Freiburg/Labjournals#irif_lab">&lt;&lt; Back</A></DIV><DIV class="content_box"><H1 class="sectionedit1">iRIf Labjournal July</H1><H3 class="sectionedit2">Measuring spotted ABs from rabbit/mouse/goat with anti-mouse/anti-rabbit</H3><DIV class="level3"><P><STRONG>30.07.2015</STRONG></P><P>
Spotted:
</P><DIV class="table sectionedit3"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-3 </TD><TD class="col1"> AB from mouse </TD><TD class="col2"> 1.0 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 4-6 </TD><TD class="col1"> AB from rabbit </TD><TD class="col2"> 1 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 10 </TD><TD class="col1"> AB from Goat (negative control) </TD></TR><TR class="row4"><TD class="col0"> 11 </TD><TD class="col1"> bBSA </TD><TD class="col2"> 1.0 mg/ml </TD></TR><TR class="row5"><TD class="col0"> 7-9 </TD><TD class="col1"> GFP </TD><TD class="col2"> 1 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
Flush protocol:
</P><DIV class="table sectionedit4"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">500</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-Mouse</TD><TD class="col1">4</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0">Buffer</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-Rabbit</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row7"><TD class="col0">Buffer</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-GFP(goat;biotinylated/mouse)</TD><TD class="col1">4</TD><TD class="col2">20</TD><TD class="col3">920</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">510</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Strep-Cy5</TD><TD class="col1">10</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0">Buffer</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Results: The secondary antibodies bound properly to their corresponding antibodies derived from mouse/rabbit.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 121: binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 121: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: binding curves - different a-GFP was tested which did not bind to GFP</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 287: ROI selection</DIV></DIV></DIV></DIV><H3 class="sectionedit5">Measuring HIV,HCV,Tet,Sal with polyclonal and monoclonal ABs</H3><DIV class="level3"><P><STRONG>30.07.2015</STRONG></P><P>
Spotted:
</P><DIV class="table sectionedit6"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV(17) </TD><TD class="col2"> 2 </TD><TD class="col3"> 1.0 mg/ml </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV(10) </TD><TD class="col2"> 2 </TD><TD class="col3"> 0.74 mg/ml </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus(11) </TD><TD class="col2"> 2 </TD><TD class="col3 leftalign"> 3.75 mg/ml  </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> His-GFP </TD><TD class="col3"> 1.0 mg/ml </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3"> 0.1 mg/ml </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> Salmonella(15) </TD><TD class="col2"> 2 </TD><TD class="col3"> 6.7 mg/ml </TD></TR></TBODY></TABLE></DIV><P>
Flush protocol:
</P><DIV class="table sectionedit7"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> Reagent </TH><TH class="col1"> Step </TH><TH class="col2"> Flow rate (ul/min) </TH><TH class="col3"> Priming time </TH><TH class="col4"> Concentration </TH></TR><TR class="row1"><TD class="col0">Buffer</TD><TD class="col1">1</TD><TD class="col2">80</TD><TD class="col3">940</TD><TD class="col4">1x</TD></TR><TR class="row2"><TD class="col0 leftalign">BSA	</TD><TD class="col1">2</TD><TD class="col2">60</TD><TD class="col3">500</TD><TD class="col4">10 mg/ml</TD></TR><TR class="row3"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">3</TD><TD class="col2">60</TD><TD class="col3">510</TD><TD class="col4">1x</TD></TR><TR class="row4"><TD class="col0">Anti-GFP(goat;biotinylated)</TD><TD class="col1">4</TD><TD class="col2">20</TD><TD class="col3">920</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row5"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">5</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row6"><TD class="col0">Anti-HIV (polyclonal)</TD><TD class="col1">6</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row7"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">7</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row8"><TD class="col0">Anti-HCV (polyclonal)</TD><TD class="col1">8</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row9"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">9</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row10"><TD class="col0">Strep-Cy5</TD><TD class="col1">10</TD><TD class="col2">30</TD><TD class="col3">600</TD><TD class="col4">5 ug/ml</TD></TR><TR class="row11"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">11</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row12"><TD class="col0">Anti-Tetanus (mk: HYB 278-15)</TD><TD class="col1">12</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">20 ug/ml</TD></TR><TR class="row13"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">13</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR><TR class="row14"><TD class="col0">Anti-Salmonella (1301 Elu2)</TD><TD class="col1">14</TD><TD class="col2">20</TD><TD class="col3">900</TD><TD class="col4">1.6 mg/ml 1:4</TD></TR><TR class="row15"><TD class="col0 leftalign">Buffer	</TD><TD class="col1">15</TD><TD class="col2">60</TD><TD class="col3">300</TD><TD class="col4">1x</TD></TR></TBODY></TABLE></DIV><P>
Results: Experiment was conducted in duplicate. Both measurements showed no antibody/antigen binding. Positive
controls (GFP/anti-GFP, bBSA/Strep) performed well.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 215: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 215: ROI selection</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 467: Binding curves</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Slide 467: ROI selection</DIV></DIV></DIV></DIV><H3 class="sectionedit8">Measuring cell free expressed His-tYFP on Ni-NTA surface</H3><DIV class="level3"><P><STRONG>28.07.2015</STRONG></P><P>
Spotting pattern:
</P><DIV class="table sectionedit9"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH></TR><TR class="row1"><TD class="col0"> 1 </TD><TD class="col1"> pIG15-104 Bernhard </TD></TR><TR class="row2"><TD class="col0"> 2 </TD><TD class="col1"> pIG15-105 Bernhard </TD></TR><TR class="row3"><TD class="col0"> 3 </TD><TD class="col1"> mCherry Lysate (HA-Tag)</TD></TR><TR class="row4"><TD class="col0"> 4 </TD><TD class="col1"> pIG15-104 Promega </TD></TR><TR class="row5"><TD class="col0"> 5 </TD><TD class="col1"> pIG15-105 Promega </TD></TR><TR class="row6"><TD class="col0"> 6 </TD><TD class="col1"> negative control with Promega </TD></TR><TR class="row7"><TD class="col0"> 10 </TD><TD class="col1"> pIG15-104 Retikulo </TD></TR><TR class="row8"><TD class="col0"> 11 </TD><TD class="col1"> pIG15-105 Retikulo </TD></TR><TR class="row9"><TD class="col0"> 7+8 </TD><TD class="col1"> Max-GFP 1mg/mL </TD></TR><TR class="row10"><TD class="col0"> 9 </TD><TD class="col1"> bBSA 100µg/mL </TD></TR></TBODY></TABLE></DIV><P>
Results: They may be (proabaly) a very weak a-tYFP/tYFP binding. Yet, the concentration of cell free expressed tYFP is probably too less to see a convincing signal.
</P><P>
 * protein spots incubated for 24 h at 4 °C
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve for S1: Only with lots of zooming anti-tYFP can be seen to bind tYFP (spot 4) within the binding curves (Exp. 36b)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Quotient picture (before/after anti-tYFP): Weak signal for Spot 4 can be seen</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve for S2: Only with lots of zooming anti-tYFP can be seen to bind tYFP (spot 4) within the binding curves (Exp. 36b)</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Quotient picture that was taken for spot marking</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Quotient picture (before/after anti-tYFP): Weak signal for Spot 4 can be seen</DIV></DIV></DIV></DIV><H3 class="sectionedit10">Measuring HIV, HCV, Salmonella, Tetanus (spotted) on Ni-NTA surface</H3><DIV class="level3"><P><STRONG>24.07.2015</STRONG></P><P>
Spotting pattern: </P><DIV class="table sectionedit11"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0"> # </TH><TH class="col1"> spot </TH><TH class="col2"> Elution no. </TH><TH class="col3"> Concentration </TH><TH class="col4"> Antibody </TH><TH class="col5"> AB-conc.[µg/ml] </TH></TR><TR class="row1"><TD class="col0"> 1-2 </TD><TD class="col1"> HIV(17) </TD><TD class="col2"> 2 </TD><TD class="col3"> 0.36 mg/ml </TD><TD class="col4"> gp41 DDX1306 </TD><TD class="col5"> 20 </TD></TR><TR class="row2"><TD class="col0"> 3-4 </TD><TD class="col1"> HCV(10) </TD><TD class="col2"> Mix (1-3)</TD><TD class="col3"> 0.13 mg/ml </TD><TD class="col5"> 20 </TD></TR><TR class="row3"><TD class="col0"> 5-6 </TD><TD class="col1"> Tetanus(11) </TD><TD class="col2"> Mix (1-3) </TD><TD class="col3"> 0.55 mg/ml </TD><TD class="col4">HYB 278-01 </TD><TD class="col5"> 20 </TD></TR><TR class="row4"><TD class="col0"> 7-8 </TD><TD class="col1"> GFP </TD><TD class="col3"> 1.0 mg/ml </TD><TD class="col4"> a-GFP (goat;biotinylated)</TD><TD class="col5"> 5 </TD></TR><TR class="row5"><TD class="col0"> 9 </TD><TD class="col1"> bBSA </TD><TD class="col3"> 0.2 mg/ml </TD><TD class="col4">Strep-Cy5 </TD><TD class="col5"> (Strep-Cy5) 10 </TD></TR><TR class="row6"><TD class="col0"> 10-11 </TD><TD class="col1"> Salmonella(15) </TD><TD class="col2"> 2 </TD><TD class="col3"> 3.2 mg/ml </TD><TD class="col4"> a-Salmonella-(pIG15_1301)</TD><TD class="col5"> 100 </TD></TR><TR class="row7"><TD class="col4">anti-His (mouse)</TD><TD class="col5">20</TD></TR></TBODY></TABLE></DIV><P>
pIG_803 / Rubella - (0.13 mg/ml) - not spotted
</P><P>
Two slides were spotted. For first slide the (max.) concentrations of the Antigens were used. For the second
slide the second spot of each Antigen was spotted diluted (100 µg/ml).
Incubation o/n for the binding to the surface.
</P><P>
After taking of the spotting mask and washing with PBS, slides were kept in fridge (4°) under wet conditions.
</P><P>
Measuring: No specific antigen/antibody binding could be detected (see graph of the binding curves).
Anti-GFP signal (positive control) was good. Strep-Cy5 signal (which bound to the biotinylated a-GFP aswell) was good. Yet, the presents of the (not His-tagged) bBSA –&gt; unspecific binding. Anti-His binding revealed that at least Tetanus and Salmonella antigen (or something with a His-Tag) are present on the slide. 
Unfortunately, the monoclonal antibodies do not bind to the expressed and spotted antigens. In case of HIV and HCV also the concentration of the antigen might be limiting. 
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve of S2: No specific antibody/antigen binding can be seen</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curve of S1: results are equal to S2 (anti-Salm not present within this plot, since huge airbubble before the step destroyed further measurement)</DIV></DIV></DIV></DIV><H3 class="sectionedit12">Measuring HIV, HCV, Salmonella, Tetanus, GFP</H3><DIV class="level3"><P><STRONG>20.07.2015</STRONG>
The antigens were stamped with PDMS stamps (50µl each) on slides (S8,S9) (see sceme of the setup). Blocking was performed for 30 min with 2 mg BSA and by contact with a PDMS slide. For each antigen, 330 µl of antibody solution was run over the slide during the measurement. To assure good binding, an excess of antibody was used (<EM>20 µg/ml</EM> instead of the normally sufficient <EM>5 µg/ml</EM>)
</P><DIV class="table sectionedit13"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0 leftalign"> Antigen     </TH><TH class="col1 leftalign"> Stamped [µg/ml]  </TH><TH class="col2"> Antibody [µg/ml] </TH></TR><TR class="row1"><TD class="col0 leftalign"> HIV <EM>(pIG15_1703)</EM></TD><TD class="col1"> 400</TD><TD class="col2"> 20 </TD></TR><TR class="row2"><TD class="col0"> HCV <EM>(pIG15_1003)</EM></TD><TD class="col1"> 400</TD><TD class="col2">20 </TD></TR><TR class="row3"><TD class="col0 leftalign"> Salmonella <EM>(pIG15_1503)</EM></TD><TD class="col1"> 500</TD><TD class="col2">20 </TD></TR><TR class="row4"><TD class="col0 leftalign"> Tetanus <EM>(pIG15_1103)</EM></TD><TD class="col1"> 500</TD><TD class="col2">20 </TD></TR><TR class="row5"><TD class="col0 leftalign"> GFP   </TD><TD class="col1"> 200</TD><TD class="col2">10 </TD></TR></TBODY></TABLE></DIV><P><STRONG>Results (S9):</STRONG> GFP/anti-GFP binding was observed, however none of the antigen/antibody pairs showed any binding. Since anti-GFP bound successfully to GFP, mistakes in slide preparation can be excluded, hinting that the antigen/antibody couples are either not able to bind due to wrong epitopes, or that too many proteins are co-purified with the antigens, leading to a very low antigen concentration on the stamps. Westerblots would be an advisable next step to assure that the antibodies are capable of binding to the epitopes of the corresponding antigens.
</P><P>
The anti-salmonella (pIG15_1303) showed strong unspecific binding on the whole slide, confirming previous observations. This might still be due to denaturation problems with the salmonella elutions.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Sceme of the setup</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">GFP Positive control - Binding of anti-GFP to GFP is visible</DIV></DIV></DIV><P><STRONG>21.07.2015</STRONG>
For the duplicate slide (S8), which was prepared in the same manner, even higher antibody concentrations were used to exclude concentration limitations.
</P><DIV class="table sectionedit14"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col0 leftalign"> Antigen     </TH><TH class="col1 leftalign"> Stamped [µg/ml]  </TH><TH class="col2"> Antibody [µg/ml] </TH></TR><TR class="row1"><TD class="col0 leftalign"> HIV <EM>(pIG15_1703)</EM></TD><TD class="col1"> 400</TD><TD class="col2">50 </TD></TR><TR class="row2"><TD class="col0"> HCV <EM>(pIG15_1003)</EM></TD><TD class="col1"> 400</TD><TD class="col2">50 </TD></TR><TR class="row3"><TD class="col0 leftalign"> Salmonella <EM>(pIG15_1503)</EM></TD><TD class="col1"> 500</TD><TD class="col2">100 </TD></TR><TR class="row4"><TD class="col0 leftalign"> Tetanus <EM>(pIG15_1103)</EM></TD><TD class="col1"> 500</TD><TD class="col2">50 </TD></TR><TR class="row5"><TD class="col0 leftalign"> GFP   </TD><TD class="col1"> 200</TD><TD class="col2">5 </TD></TR></TBODY></TABLE></DIV><P>
Again, a-GFP to GFP binding could be detected well. Unfortunately, no binding of any antibodies to the antigens could be observed.
Binding curve analyses follows…
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Binding curves slide S8: Evaluation of the binding curves confirms that no binding process for any antibody/antigen pair occured</DIV></DIV></DIV></DIV><H3 class="sectionedit15">Stamping Cell-free YFP (Promega Kit)</H3><DIV class="level3"><P><STRONG>19.07.2015</STRONG>
A stamp with freshly, cell-free expressed YFP (approx 20µl) was stamped onto an iGEM stamp. A GFP stamp was stamped as control. Blocking was performed for 30min with 10mg/ml BSA, then blocked with a PDMS slide. GFP/Anti-GFP Binding could be observed in iRIF, however no binding of anti-YFP, nor anti-HIS could be detected on the YFP stamp.
</P></DIV><H3 class="sectionedit16">Stamping unfrozen pIG15_1501 Salmonella antigen</H3><DIV class="level3"><P><STRONG>19.07.2015</STRONG>
Stamped freshly eluted Salmonella antigen, which was prepared the same day. Apart from not being frozen, salmonella antigen and antibody we're both eluted in a phosphate free buffer.
While stamping, it was observed that the salmonella antigen (1501) already showed some flakes floating in the solution, indicating that the antigen is either denaturated, or that it naturally forms aggregates.
</P><P>
The Salmonella Antibody was diluted 1:10. Antigen was stamped without dilution (~3,2 mg/ml protein in solution). Controls were GFP and bBSA stamps.
Binding of Salmonella antigen to salmonella antibody could not be observed.
</P></DIV><H3 class="sectionedit17">Stamping pIG15_1501 Salmonella antigen</H3><DIV class="level3"><P><STRONG>07.07.2015</STRONG></P><P>
Salmonella-antigen (1501) and Salmonella-antibody (1301) were provided by the protein purification.
Unfortunately, after thawing antibody and antigen, both precipitated. Nevertheless, we continued (with not too great expectations).
</P><P>
To test salmonella-antibody binding to antigen the following experiment was conducted:
Stamping sceme (look setup picture). 
Flush protocol:
- PBS (baseline)
- BSA (blocking) (500 ug/ml)
- PBS
- Anti-Salmonella (1301) (0.5 mg/ml!)
- PBS
- Anti-GFP (5 ug/ml)
- PBS
- bBSA (200 ug/ml)
</P><P>
Some airbubbles came into chamber by initial flooding. Continued measurement. Blocking was fine. When anti-Salmonella was flushed over the slide, an intensense signal on the whole slide was seen; this is probably due to high unspecific binding. Then (as can be seen within the graph of the binding curves) specific binding of the a-Salmonella to the Salmonella-antigen stamp is detectable. Positive control (GFP / anti-GFP) was positive. bBSA to StrepCy5 was not detectable - this was not that surprising; already plate reader after stamping process revealed low transfer of StrepCy5 to the surface / denaturation of the protein.
–&gt; We have to repeat the experiment with unprecipitated antibody/antigen, maybe another surface for less unspecific binding and longer baseline/blocking/binding steps, but in general the antibody seems to bind to the antigen (see increase in intensity within a-Salmonella-step at the Salmonella spots - delta to the baseline)
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Setup of the experiment</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Evaluation of binding experiment with 1501/1301</DIV></DIV></DIV></DIV><H3 class="sectionedit18">Testing stamping technique</H3><DIV class="level3"><P><STRONG>07.07.2015</STRONG></P><P>
Investigating optimal stamping technique:
</P><P>
Pressure (slide 467): 3 stamps StrepCy5 (50 ug/ml) → without pressure (just put on the slide)/pushed very soft/pushed hard - all incubated for ~30s
</P><P>
Incubation time (Slide 303): 3 stamps StrepCy5 (50 ug/ml) → 1 minute / 5 minutes / 30 minutes - all stamps without pressure
As can be seen in the platereader pictures, no differences between different pressures or incubationtimes is detectable.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Stamping with different pressures (constant incubation ~1min): Top → no pressure, bottom right → minimum pressure, bottom left → high pressure </DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">Stamping with different incubation time (constant pressure (no pressure): Top → 1 minute, bottom right → 5 minutes. bottom left → 30 minutes </DIV></DIV></DIV></DIV><H3 class="sectionedit19">Stamping pIG15_1501 Salmonella antigen</H3><DIV class="level3"><P><STRONG>01.07.2015</STRONG>
This experiment focuses on trying to see whether our salmonella antigen (pIG15_1501) is bound by our salmonella antibody (pIG15_1301).
pIG15_1501 (Salmonella antigen) eluation 1 was taken from the -80 freezer. When melting the ~10mg/ml tube, we observed that the antigen appeared to be denaturated, hinting that the storage conditions were not tolerated by the protein. The supernatant was used nonetheless, hoping that some protein might still be correctly folded. The antibody (0,5 mg/ml) was diluted 1:2 in PBS. 
A plasma-activated slide was used for measurement. A DiaCHIP stamp was incubated with undiluted antigen supernatant. An iGEM stamp was incubated with StrepCY5, an antibody-shaped stamp was incubated with GFP (200µg/ml) for 30 min. After blocking the slide in BSA, a fluorescence measurement was performed to control for correct stamping. The StrepCY5 stamp showed hardly any fluorescence in the plate reader. This indicates bad stamping (wrong pressure, hardly any pressure was applied this time) or faulty StrepCY5. 
</P><P>
Anti-Salmonella showed stong unspecific binding to the whole slide, however no binding to the antigen was detected. This doesn't come as a surprise since the antigen appeared to be denaturated. Anti-GFP showed specific binding to GFP.
</P><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption">iRIf picture of anti-GFP binding step - correct binding to the stamped GFP spot</DIV></DIV></DIV><DIV class="thumb2 trien" style="width:210px"><DIV class="thumbinner"><DIV class="thumbcaption"> iRIf picture of anti-salmonella binding step - unspecific binding to the whole slide</DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>